Cancer cells undergo metabolic reprogramming to meet the increased demands for energy and biosynthetic precursors required for rapid proliferation. This reprogramming involves alterations in various metabolic pathways, including glucose, amino acid, and lipid metabolism. These changes are driven by oncogenes and tumor suppressor genes, as well as the tumor microenvironment.
